Publikationer 2017

Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction.

Vedin O, Lam CSP, Koh AS, Benson L, Teng THK, Tay WT, Braun OÖ, Savarese G, Dahlström U, Lund LH.

Circ Heart Fail 2017 Jun;10(6)


Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators.

Bilchick KC, Wang Y, Cheng A, Curtis JP, Dharmarajan K, Stukenborg GJ, Shadman R, Anand I, Lund LH, Dahlström U, Sartipy U, Maggioni A, Swedberg K, O'Conner C, Levy WC.

J Am Coll Cardiol. 2017 May 30;69(21):2606-2618


Prevalence and Clinical Significance of Diabetes in Asian Versus White Patients With Heart Failure

Bank IEM, Gijsberts CM, Teng TK, Benson L, Sim D, Yeo PSD, Ong HY, Jaufeerally F, Leong GKT, Ling LH, Richards AM, de Kleijn DPV, Dahlström U, Lund LH, Lam CSP.

JACC Heart Fail. 2017 Jan;5(1):14-24


Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction

Löfman I, Szummer K, Dahlström U, Jernberg T, Lund LH

Eur J Heart Fail. 2017 Dec;19(12):1606-1614


Association Between Use of Long-Acting Nitrates and Outcomes in Heart Failure With Preserved Ejection Fraction

Lim SL, Benson L, Dahlström U, Lam CS, Lund LH

Circ Heart Fail. 2017 Apr 10(4)


Association between enrolment in a heart failure quality registry and subsequent mortality—a nationwide cohort study.

Lund LH, Carrero JJ, Farahmand B, Henriksson K, Jonsson Å, Jernberg T, Dahlström U

Eur J Heart Fail 2017 Sep: 19(9):1107-1116


A comprehensive population-based characterization of heart failure with mid-range ejection fraction.

Koh AS, Tay WT, Teng THK, Vedin O, Benson L, Dahlstrom U, Savarese G, Lam CSP, Lund LH

European Journal of Heart Failure (2017) 19, 1624–1634